Major Radhika Sen has been honoured with the United Nations Gender Advocate Award, becoming the second Indian peacekeeper to ...

Exelixis (EXEL) has recently gained traction in the rapidly growing oncology market with its promising pipeline and strong ...

Following a constructive Nasdaq hearing panel on January 7, 2025, Evaxion has been granted a 180-day extension in relation to the Nasdaq minimum ...

The Music Academy of the West recently named its 2025 Board officers and added four new members of the community to the board. “This board will help grow ...

Learn both soft and hard skills, increase your job prospects, boost your salary capacity and engage in real-world problem ...

Vir Biotechnology, Inc ... Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of ...

In 2024, Fierce Biotech reported 192 industry layoff rounds, which is 3% higher than in 2023, when 187 rounds were tallied. Rounds are reported as they are disclosed and are not combined per ...

The degrees in the 100 most popular courses ... rose almost nine points to 80.4 and the bachelor of molecular biotechnology rose 10 points to 85 between 2015 and this year. University Admissions ...

Re­gen­eron, mak­er of the block­buster oph­thal­mol­o­gy med­i­cine Eylea, has ac­quired an oc­u­lar biotech, the large bio­phar­ma con­firmed to End­points News on Thurs­day.

No Oxular employees are joining Regeneron, though several will be “helping short-term with tech transfer and transition work in consulting roles,” a Regeneron spokesperson told Fierce Biotech ...